Innova Captab Limited — Board Meeting, 07-11-2025: Outcome of Board Meeting
07-11-2025 | 05:16 pm
07-11-2025 | 05:16 pm
Innova Captab's board approved Q2 & H1 consolidated financial results, with half-year PBT at ₹81.91 Cr. Separately, Devendra Palav was redesignated as Manager, retaining his CEO role, at subsidiary Sharon Bio-Medicine.
No comments yet. Be the first to comment!
